ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA.DL)
CAPS Rating:
An ophthalmic pharmaceutical company, focused on the development and commercialization of products for serious diseases and conditions of the eye.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked ISTA.DL yet. Tell us why you think ISTA.DL will outperform or underperform the market.
RSS Headlines
Fool UK
